Showing results (331-340 of 374) with videos related to

Sort By:
Pageof 38
Lupus|December 17, 2008
Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome?Z Rotar, B Rozman, P G de Groot, et al.
Lupus|June 3, 2016
International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodiesC Bentow, G Lakos, P Martis, et al.
Lupus|August 28, 2014
Carotid atherosclerosis is not associated with lower bone mineral density and vertebral fractures in patients with systemic lupus erythematosusC Mendoza-Pinto, M García-Carrasco, M Jiménez-Hernández, et al.
Lupus|July 22, 2010
Prolactin's role in the pathogenesis of the antiphospholipid syndromeS Praprotnik, N Agmon-Levin, B S Porat-Katz, et al.
Nature|October 3, 2000
IRS-2 pathways integrate female reproduction and energy homeostasisD J Burks, J Font de Mora, M Schubert, et al.
Lupus|December 6, 2012
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosusD J Wallace, S Navarra, M A Petri, et al.
Rheumatology (Oxford, England)|June 28, 2006
Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosusJ Font, M Ramos-Casals, P Brito-Zerón, et al.
Annals of the Rheumatic Diseases|October 29, 2010
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expressionN Agmon-Levin, M Blank, G Zandman-Goddard, et al.
Lupus|October 5, 2018
The anti-thrombotic effects of vitamin D and their possible relationship with antiphospholipid syndromeM García-Carrasco, E A Jiménez-Herrera, J L Gálvez-Romero, et al.
Lupus|August 31, 2013
Bone mineral density in systemic lupus erythematosus women one year after rituximab therapyC Mendoza Pinto, M García Carrasco, I Etchegaray Morales, et al.
Pageof 38